While some are still in the clinical trial stage, the following vaccines are currently available: Pediarix is a combination vaccine that combines the immunizations for Diphtheria, Tetanus and acellular Pertussis (DTaP), Hepatitis B and inactivated Polio (IPV), which used to require three separate shots. Pediarix is given to children as a three dose series at 2, 4, and 6 months. So instead of 9 shots for the series to get protection against Diptheria, Tetanus, Pertussis (Whooping Cough), Hepatitis B and Polio, you can now get the same protection for your kids in just 3 shots.
In all clinical trials, the typical process starts with a screening period. The screening period starts with the signing of the informed consent. During the screening period, inclusion/exclusion criteria for the study participation will be checked / tested. Subjects who meet all inclusion criteria and do not meet any exclusion criterion will be eligible to be randomized (in randomized trial) or to be dosed (in non-randomized trial).
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents.